Ignite Creation Date:
2025-12-25 @ 1:20 AM
Ignite Modification Date:
2026-02-28 @ 10:38 PM
Study NCT ID:
NCT01551693
Status:
TERMINATED
Last Update Posted:
2017-04-12
First Post:
2011-04-29
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
STA-9090(Ganetespib) in Patients With Unresectable Stage III or Stage IV Melanoma
Sponsor:
Dana-Farber Cancer Institute
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-09
Start Date Type:
None
Primary Completion Date:
2012-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2012-09
Completion Date Type:
ACTUAL
First Submit Date:
2011-04-29
First Submit QC Date:
None
Study First Post Date:
2012-03-13
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2016-12-21
Results First Submit QC Date:
None
Results First Post Date:
2017-04-12
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-03-01
Last Update Post Date:
2017-04-12
Last Update Post Date Type:
ACTUAL